韩国的成人免疫政策。
Adult Immunization Policy in Korea.
作者信息
Choi Won Suk
机构信息
Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
出版信息
Infect Chemother. 2023 Sep;55(3):317-321. doi: 10.3947/ic.2023.0089.
Abstract
Although adult immunization is different from children's, vaccine preventable diseases (VPDs) for adults are significant in that they are more severe and cause more deaths than VPDs for children. Additionally, the emergence of new vaccines and an increase in the elderly population are increasing demands for policy support for adult vaccination. Accordingly, in this paper, I will look at the characteristics of adult immunization, policies that have been implemented in Korea, and considerations.
摘要
虽然成人免疫接种与儿童不同，但成人的疫苗可预防疾病（VPDs）意义重大，因为与儿童的VPDs相比，它们更为严重且导致更多死亡。此外，新疫苗的出现和老年人口的增加，对成人疫苗接种政策支持的需求也在增加。因此，在本文中，我将探讨成人免疫接种的特点、韩国已实施的政策以及相关考虑因素。
相似文献
1
Adult Immunization Policy in Korea.韩国的成人免疫政策。
Infect Chemother. 2023 Sep;55(3):317-321. doi: 10.3947/ic.2023.0089.
2
Barriers for vaccination of healthcare workers.医护人员疫苗接种的障碍。
Hum Vaccin Immunother. 2021 Sep 2;17(9):3073-3076. doi: 10.1080/21645515.2021.1904760. Epub 2021 Apr 27.
3
National vaccination policies for health workers - A cross-sectional global overview.卫生工作者的国家疫苗接种政策——全球横断面概述。
Vaccine. 2024 Feb 6;42(4):757-769. doi: 10.1016/j.vaccine.2023.04.083. Epub 2023 Jun 14.
4
The need for vaccination in adults with chronic (noncommunicable) diseases in India - lessons from around the world.印度慢性（非传染性）疾病成人接种疫苗的需求——来自世界各地的经验教训。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2052544. doi: 10.1080/21645515.2022.2052544. Epub 2022 Apr 13.
5
The role of epidemiology in informing United States childhood immunization policy and practice.流行病学在告知美国儿童免疫政策和实践方面的作用。
Ann Epidemiol. 2021 Oct;62:100-114. doi: 10.1016/j.annepidem.2020.09.017. Epub 2020 Oct 14.
6
An Examination of Employee Immunization Policies Among Colorado Child Care Providers.科罗拉多州儿童保育机构员工免疫政策调查
J Pediatric Infect Dis Soc. 2021 Jul 28. doi: 10.1093/jpids/piab062.
7
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective.免疫功能低下成人疫苗接种未满足医学需求的综述：印度视角。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2224186. doi: 10.1080/21645515.2023.2224186.
8
Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015.疫苗可预防的死亡与《2006 - 2015年全球免疫远景与战略》
MMWR Morb Mortal Wkly Rep. 2006 May 12;55(18):511-5.
9
An Immune Recovery-Based Revaccination Protocol for Pediatric Hematopoietic Stem Cell Transplant Recipients: Revaccination Outcomes Following Pediatric HSCT.基于免疫恢复的儿科造血干细胞移植受者再接种方案：儿科 HSCT 后的再接种结果。
Transplant Cell Ther. 2021 Apr;27(4):317-326. doi: 10.1016/j.jtct.2021.01.017. Epub 2021 Jan 28.
10
Changes in epidemiological features of vaccine preventable infectious diseases among three eras of national vaccination strategies from 1953 to 2018 in Shanghai, China.1953年至2018年中国上海国家疫苗接种策略三个阶段中疫苗可预防传染病的流行病学特征变化
Lancet Reg Health West Pac. 2021 Jan 23;7:100092. doi: 10.1016/j.lanwpc.2021.100092. eCollection 2021 Feb.
引用本文的文献
1
Therapeutic Vaccines for Non-Communicable Diseases: Global Progress and China's Deployment Pathways.非传染性疾病治疗性疫苗：全球进展与中国的部署路径
Vaccines (Basel). 2025 Aug 20;13(8):881. doi: 10.3390/vaccines13080881.
2
Influenza disease burden and the need for highly immunogenic vaccines in older adults: a narrative review.老年人的流感疾病负担及对高免疫原性疫苗的需求：一项叙述性综述
Ewha Med J. 2024 Jul;47(3):e35. doi: 10.12771/emj.2024.e35. Epub 2024 Jul 31.
3
Reply: How Can Chronic COVID (Long-COVID Syndrome) Be Diagnosed and Treated?回复：慢性新冠（长新冠综合征）如何诊断与治疗？
Infect Chemother. 2024 Dec;56(4):561-563. doi: 10.3947/ic.2024.0134.
4
Burden of Herpes Zoster in Individuals With Chronic Conditions in the Republic of Korea: A Nationwide Population-Based Database Study.韩国慢性病患者的带状疱疹负担：一项基于全国人口数据库的研究。
Open Forum Infect Dis. 2024 Sep 18;11(10):ofae535. doi: 10.1093/ofid/ofae535. eCollection 2024 Oct.
5
Updated Clinical Practice Guidelines for the Diagnosis and Management of Long COVID.《长新冠诊断与管理的更新临床实践指南》
Infect Chemother. 2024 Mar;56(1):122-157. doi: 10.3947/ic.2024.0024. Epub 2024 Mar 13.
6
Prioritizing Adult Immunization in the Philippines.菲律宾成人免疫接种工作的优先安排
Infect Chemother. 2023 Dec;55(4):519-520. doi: 10.3947/ic.2023.0103.
7
Invasive Pneumococcal Diseases in Korean Adults After the Introduction of Pneumococcal Vaccine into the National Immunization Program.肺炎球菌疫苗纳入国家免疫规划后韩国成年人侵袭性肺炎球菌疾病情况
Infect Chemother. 2023 Dec;55(4):411-421. doi: 10.3947/ic.2023.0112.
8
Response to "Adult Immunization Policy in Korea".对《韩国成人免疫政策》的回应
Infect Chemother. 2024 Mar;56(1):88-89. doi: 10.3947/ic.2023.0108. Epub 2023 Dec 13.
9
Estimating the medical capacity required to administer mass prophylaxis: a hypothetical outbreak of smallpox virus infection in Korea.估算大规模预防接种所需的医疗能力：韩国假设的天花病毒感染爆发。
Epidemiol Health. 2019;41:e2019044. doi: 10.4178/epih.e2019044. Epub 2019 Oct 10.
10
Surveillance and compensation claims for adverse events following immunization from 2011 to 2016 in the Republic of Korea.2011年至2016年韩国免疫接种后不良事件的监测与补偿索赔
Clin Exp Vaccine Res. 2017 Jul;6(2):146-155. doi: 10.7774/cevr.2017.6.2.146. Epub 2017 Jul 26.
本文引用的文献
1
COVID-19 Vaccination in Korea.韩国的新冠疫苗接种情况。
Infect Chemother. 2023 Mar;55(1):135-149. doi: 10.3947/ic.2023.0023.
2
Clinical Characteristics and Risk Factors for Severe Disease of Coronavirus Disease 2019 in a Low Case Fatality Rate Region in Korea.韩国低病死率地区2019冠状病毒病重症的临床特征及危险因素
Infect Chemother. 2021 Dec;53(4):718-729. doi: 10.3947/ic.2021.0104. Epub 2021 Dec 16.
3
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.制定大流行 COVID-19 疫苗分配框架：韩国的一项改良德尔菲共识研究。
J Korean Med Sci. 2021 Jun 14;36(23):e166. doi: 10.3346/jkms.2021.36.e166.
4
Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries.低收入和中等收入国家成人疫苗可预防疾病的情况评估以及免疫宣传与政策的潜力。
Vaccine. 2021 Mar 12;39(11):1556-1564. doi: 10.1016/j.vaccine.2021.01.066. Epub 2021 Feb 19.
5
Age-Related Morbidity and Mortality among Patients with COVID-19.新型冠状病毒肺炎患者的年龄相关发病率和死亡率
Infect Chemother. 2020 Jun;52(2):154-164. doi: 10.3947/ic.2020.52.2.154. Epub 2020 Jun 12.
6
Cost-effectiveness of adult vaccinations: A systematic review.成人疫苗接种的成本效益：系统评价。
Vaccine. 2019 Jan 7;37(2):226-234. doi: 10.1016/j.vaccine.2018.11.056. Epub 2018 Dec 4.
7
The Korean Influenza National Immunization Program: History and Present Status.韩国流感国家免疫规划：历史与现状
Infect Chemother. 2017 Dec;49(4):247-254. doi: 10.3947/ic.2017.49.4.247.
8
Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.50 岁及以上成人中重组流感疫苗的效果。
N Engl J Med. 2017 Jun 22;376(25):2427-2436. doi: 10.1056/NEJMoa1608862.
9
Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.2013年美国四种主要成人疫苗可预防疾病的估计人力和经济负担
J Prim Prev. 2015 Aug;36(4):259-73. doi: 10.1007/s10935-015-0394-3.
10
Vaccination policy in Korean armed forces: current status and future challenge.韩国武装部队的疫苗接种政策：现状与未来挑战。
J Korean Med Sci. 2015 Apr;30(4):353-9. doi: 10.3346/jkms.2015.30.4.353. Epub 2015 Mar 19.
Zotero 插件